149 followers
@EladSharonMD You are right, even though our retrospective data on the use of Pembro/Lenvatinib as an advanced line for Melanoma has shown some potential, despite the failure of the Leap003 trial. https://t.co/A8wKvjR9jE
@EladSharonMD You are right, even though our retrospective data on the use of Pembro/Lenvatinib as an advanced line for Melanoma has shown some potential, despite the failure of the Leap003 trial. https://t.co/A8wKvjR9jE
RT @RonenStoff: So happy to share out latest work - the first published series of real world evidence of Lenvatinib + anti PD-1 as an advan…
So happy to share out latest work - the first published series of real world evidence of Lenvatinib + anti PD-1 as an advanced line for metastatic melanoma https://t.co/hC3pWCAjAJ